Karonudib is a promising anticancer therapy in hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/1758835919866960
Abstract: Background: Hepatocellular carcinoma (HCC) is the most common form of liver cancer and is generally caused by viral infections or consumption of mutagens, such as alcohol. While liver transplantation and hepatectomy is curative for some… read more here.
Keywords: hepatocellular carcinoma; karonudib promising; hcc; mth1 ... See more keywords